Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
暂无分享,去创建一个
J. Xu | Xiao-ming Wu | H. Cai | Xiaojing Huang | Shengtao Xu | Hao Shen | Pengfei Zhang | Yue Huang | Jieyun Jiang | Yijun Sun | B. Jiang | Hequan Yao | Jingyi Xu
[1] Koshihara Yasuko,et al. Caffeic acid is a selective inhibitor for leukotriene biosynthesis , 1984 .
[2] J. Wallace,et al. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. , 1992, The American journal of physiology.
[3] B. Rigas,et al. Altered eicosanoid levels in human colon cancer. , 1993, The Journal of laboratory and clinical medicine.
[4] P. Loll,et al. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.
[5] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[6] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.
[7] J. Chow,et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.
[8] Raymond L. White,et al. Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2 , 1996, Cell.
[9] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1997, Nature.
[10] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[11] G. Zimmerman,et al. Intracellular unesterified arachidonic acid signals apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Bostwick,et al. Lipoxygenase‐5 is overexpressed in prostate adenocarcinoma , 2001, Cancer.
[13] T. Moody,et al. Five‐lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] G. Davı̀,et al. 5‐Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] J. Cameron,et al. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. , 2002, American journal of clinical pathology.
[16] A. ADoefaa,et al. ? ? ? ? f ? ? ? ? ? , 2003 .
[17] J. Andrade,et al. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. , 2003, Journal of medicinal chemistry.
[18] T. Taverne,et al. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy. , 2004, Journal of medicinal chemistry.
[19] M. Cordeiro,et al. Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. , 2004, Bioorganic & medicinal chemistry.
[20] W. Wu,et al. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. , 2004, Toxicology.
[21] K. Wakabayashi,et al. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. , 2006, Current pharmaceutical design.
[22] M. Yasuno,et al. Expression of 5-lipoxygenase in human colorectal cancer. , 2006, World journal of gastroenterology.
[23] Hirokazu Takahashi,et al. Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. , 2007, Journal of pharmacological sciences.
[24] R. Newman,et al. Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model. , 2008, Carcinogenesis.
[25] M. Jett,et al. Potential roles for inhibitors of arachidonic acid metabolism in prevention and treatment of breast cancer , 2008 .
[26] D. Bentrem,et al. Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine Model , 2008, Clinical Cancer Research.
[27] S. Chiou,et al. Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line , 2008, Child's Nervous System.
[28] X. Xie,et al. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. , 2008, Experimental oncology.
[29] A. Mantovani,et al. Cancer: Inflaming metastasis , 2008, Nature.
[30] S. Laufer,et al. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. , 2008, Carcinogenesis.
[31] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[32] M. Saini,et al. The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model. , 2009, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[33] T. Lu,et al. Design, Synthesis, and Biological Evaluation of 1,5-Diaryl-1,2,4-triazole Derivatives as Selective Cyclooxygenase-2 Inhibitors. , 2010 .
[34] Design, Synthesis, and Biological Evaluation of 1,5‐Diaryl‐1,2,4‐triazole Derivatives as Selective Cyclooxygenase‐2 Inhibitors , 2010, Archiv der Pharmazie.
[35] S. Mandal,et al. COX-2 as a target for cancer chemotherapy , 2010, Pharmacological reports : PR.
[36] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[37] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[38] A. Brash,et al. The Structure of Human 5-Lipoxygenase , 2011, Science.
[39] R. Sharmila,et al. Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. , 2012, Indian journal of experimental biology.
[40] L. Lai,et al. Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors. , 2012, Journal of medicinal chemistry.
[41] M. Wu,et al. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[42] A. Palucka,et al. Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.
[43] Buxi Shi,et al. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines. , 2013, European journal of medicinal chemistry.
[44] Jiaolin Bao,et al. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. , 2013, Cancer letters.
[45] M. Chatterjee,et al. Overexpression of 5‐lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12‐dimethylbenz(α)anthracene‐induced rat mammary carcinogenesis , 2013, Molecular carcinogenesis.
[46] A. Mavrova,et al. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety. , 2014, European journal of medicinal chemistry.
[47] Y. Liu,et al. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. , 2014, European journal of medicinal chemistry.
[48] T. Lu,et al. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. , 2014, Organic & biomolecular chemistry.
[49] Wannian Yang,et al. COX‐2 inhibitors arrest prostate cancer cell cycle progression by down‐regulation of kinetochore/centromere proteins , 2014, The Prostate.
[50] Ying Yan,et al. Sensitisation of human lung adenocarcinoma A549 cells to radiotherapy by Nimotuzumab is associated with enhanced apoptosis and cell cycle arrest in the G2/M phase , 2015, Cell biology international.
[51] A. Bode,et al. Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression , 2015, EBioMedicine.
[52] A. Bender,et al. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors. , 2015, European journal of medicinal chemistry.